Trials / Conditions / Refractory Lupus Nephritis
Refractory Lupus Nephritis
5 registered clinical trials studyying Refractory Lupus Nephritis — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Umbilical Cord Blood CD19-BCMA CART Cell Therapy for SLE-LN, SSc, andpSS PAH. NCT06947473 | Beijing GoBroad Hospital | Phase 1 / Phase 2 |
| Recruiting | A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101 NCT07403188 | Kyverna Therapeutics | — |
| Withdrawn | A Study of TAK-007 in Adults With Refractory Lupus Nephritis (LN) or Refractory Systemic Sclerosis (SSc) NCT06377228 | Takeda | Phase 1 |
| Recruiting | CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH NCT06947460 | Beijing GoBroad Hospital | Phase 1 / Phase 2 |
| Recruiting | NK010 or NK042 in Combination With Rituximab for Refractory Systemic Lupus Erythematosus/Lupus Nephritis NCT06676631 | Guangdong Provincial People's Hospital | Phase 1 |